Enhanced Peritoneal Ovarian Tumor Dissemination by Tissue Transglutaminase
Open Access
- 1 August 2007
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 67 (15) , 7194-7202
- https://doi.org/10.1158/0008-5472.can-07-0307
Abstract
Tissue transglutaminase (TG2) is involved in Ca2+-dependent aggregation and polymerization of proteins. We previously reported that TG2 mRNA is up-regulated in epithelial ovarian cancer (EOC) cells compared with normal ovarian epithelium. Here, we show overexpression of the TG2 protein in ovarian cancer cells and tumors and its secretion in ascites fluid and define its role in EOC. By stable knockdown and overexpression, we show that TG2 enhances EOC cell adhesion to fibronectin and directional cell migration. This phenotype is preserved in vivo, where the pattern of tumor dissemination in the peritoneal space is dependent on TG2 expression levels. TG2 knockdown diminishes dissemination of tumors on the peritoneal surface and mesentery in an i.p. ovarian xenograft model. This phenotype is associated with deficient β1 integrin-fibronectin interaction, leading to weaker anchorage of cancer cells to the peritoneal matrix. Highly expressed in ovarian tumors, TG2 facilitates i.p. tumor dissemination by enhancing cell adhesion to the extracellular matrix and modulating β1 integrin subunit expression. [Cancer Res 2007;67(15):7194–202]Keywords
All Related Versions
This publication has 40 references indexed in Scilit:
- Overexpression of Tissue Transglutaminase Leads to Constitutive Activation of Nuclear Factor-κB in Cancer Cells: Delineation of a Novel PathwayCancer Research, 2006
- Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cellsOncogene, 2006
- Tissue transglutaminase 2 inhibition promotes cell death and chemosensitivity in glioblastomasMolecular Cancer Therapeutics, 2005
- RNA Interference Demonstrates a Novel Role for Integrin-Linked Kinase as a Determinant of Pancreatic Adenocarcinoma Cell Gemcitabine ChemoresistanceClinical Cancer Research, 2005
- Proinvasive Properties of Ovarian Cancer Ascites-Derived Membrane VesiclesCancer Research, 2004
- Augmentation of Tissue Transglutaminase Expression and Activation by Epidermal Growth Factor Inhibit Doxorubicin-induced Apoptosis in Human Breast Cancer CellsJournal of Biological Chemistry, 2004
- αv integrins regulate cell proliferation through integrin-linked kinase (ILK) in ovarian cancer cellsOncogene, 2003
- Transglutaminases: crosslinking enzymes with pleiotropic functionsNature Reviews Molecular Cell Biology, 2003
- Expression of cell adhesion molecules on ovarian tumour cell lines and mesothelial cells, in relation to ovarian cancer metastasisCancer Letters, 1995
- Increased levels of laminin in ascitic fluid of patients with ovarian cancerCancer Letters, 1995